These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9519838)

  • 21. Expression, purification, crystallization and preliminary crystallographic analysis of hepatitis B virus core protein dimerized via a peptide linker containing an EGFP insertion.
    Kikuchi M; Iwabuchi S; Kikkou T; Noguchi K; Odaka M; Yohda M; Kawata M; Sato C; Matsumoto O
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Aug; 69(Pt 8):942-5. PubMed ID: 23908049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA.
    Köck J; Nassal M; Deres K; Blum HE; von Weizsäcker F
    J Virol; 2004 Dec; 78(24):13812-8. PubMed ID: 15564489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein.
    Birnbaum F; Nassal M
    J Virol; 1990 Jul; 64(7):3319-30. PubMed ID: 2191149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple roles of PP2A binding motif in hepatitis B virus core linker and PP2A in regulating core phosphorylation state and viral replication.
    Xi J; Luckenbaugh L; Hu J
    PLoS Pathog; 2021 Jan; 17(1):e1009230. PubMed ID: 33493210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impacts on hepatitis B virus replication by gene engineering at apical loop region of capsid protein].
    Chen J; Huang R; Tao Y; Huang Y; Luo Y; Huang A; Hu J
    Sheng Wu Gong Cheng Xue Bao; 2013 Nov; 29(11):1663-71. PubMed ID: 24701831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells.
    Yamamoto M; Hayashi N; Takehara T; Ueda K; Mita E; Tatsumi T; Sasaki Y; Kasahara A; Hori M
    Hepatology; 1999 Jul; 30(1):300-7. PubMed ID: 10385671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A structural model for duck hepatitis B virus core protein derived by extensive mutagenesis.
    Nassal M; Leifer I; Wingert I; Dallmeier K; Prinz S; Vorreiter J
    J Virol; 2007 Dec; 81(23):13218-29. PubMed ID: 17881438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
    Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
    Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles.
    Preikschat P; Kazaks A; Dishlers A; Pumpens P; Krüger DH; Meisel H
    FEBS Lett; 2000 Jul; 478(1-2):127-32. PubMed ID: 10922483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The method of noncovalent in vitro binding of target proteins to virus-like nanoparticles formed by core antigen of hepatitis B virus.
    Blokhina EA; Kupriyanov VV; Ravin NV; Skryabin KG
    Dokl Biochem Biophys; 2013; 448():52-4. PubMed ID: 23478989
    [No Abstract]   [Full Text] [Related]  

  • 32. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface.
    Watts NR; Conway JF; Cheng N; Stahl SJ; Belnap DM; Steven AC; Wingfield PT
    EMBO J; 2002 Mar; 21(5):876-84. PubMed ID: 11867516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of Mutant Hepatitis B Core Protein Capsids with Premature Secretion Phenotype.
    Böttcher B; Nassal M
    J Mol Biol; 2018 Dec; 430(24):4941-4954. PubMed ID: 30539760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically.
    Lewellyn EB; Loeb DD
    PLoS One; 2011 Feb; 6(2):e17202. PubMed ID: 21358805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids.
    Schlicksup CJ; Wang JC; Francis S; Venkatakrishnan B; Turner WW; VanNieuwenhze M; Zlotnick A
    Elife; 2018 Jan; 7():. PubMed ID: 29377794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein.
    Zlotnick A; Cheng N; Conway JF; Booy FP; Steven AC; Stahl SJ; Wingfield PT
    Biochemistry; 1996 Jun; 35(23):7412-21. PubMed ID: 8652518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of homologous interaction sites in the hepatitis B virus core protein.
    König S; Beterams G; Nassal M
    J Virol; 1998 Jun; 72(6):4997-5005. PubMed ID: 9573269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion.
    Hacker HJ; Deres K; Mildenberger M; Schröder CH
    Biochem Pharmacol; 2003 Dec; 66(12):2273-9. PubMed ID: 14637185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
    Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
    Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
    Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.